Article info

Download PDFPDF
Short report
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis

Authors

  1. Correspondence to Dr Joanne Jones, Department of Clinical Neurosciences, University of Cambridge, Box 165, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK; Jls53{at}medschl.cam.ac.uk.
View Full Text

Citation

Azzopardi L, Thompson SAJ, Harding KE, et al
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis

Publication history

  • Received October 16, 2013
  • Revised November 28, 2013
  • Accepted November 28, 2013
  • First published December 24, 2013.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.